PAR4 ETANERCEPT VERSUS INFLIXIMAB PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS- A COST-EFFECTIVENESS ANALYSIS FROM THE ITALIAN NHS PERSPECTIVE
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61849-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)61849-9/fulltext
Title :
PAR4 ETANERCEPT VERSUS INFLIXIMAB PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS- A COST-EFFECTIVENESS ANALYSIS FROM THE ITALIAN NHS PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61849-9&doi=10.1016/S1098-3015(10)61849-9
First page :
Section Title :
Open access? :
No
Section Order :
296